Increased proximal tubular cholesterol content: Implications for cell injury and “acquired cytoresistance”  by Zager, Richard A. et al.
Kidney International, Vol. 56 (1999), pp. 1788–1797
Increased proximal tubular cholesterol content: Implications
for cell injury and “acquired cytoresistance”
RICHARD A. ZAGER, KRISTIN M. BURKHART, ALI C.M. JOHNSON, and BENJAMIN M. SACKS
The Fred Hutchinson Cancer Research Center, and the University of Washington, Seattle, Washington, USA
Increased proximal tubular cholesterol content: Implications For almost a century, it has been recognized that fol-
for cell injury and “acquired cytoresistance.” lowing the induction of experimental acute renal failure
Background. Acute renal failure (ARF) leads to secondary (ARF), the kidney acquires partial resistance to further
adaptive changes that serve to protect proximal tubules from ischemic or toxic damage [1]. This phenomenon, denotedsubsequent ischemic or toxic damage [so-called “acquired cy-
by the term “acquired cytoresistance,” (CR) has the fol-toresistance” (CR)]. A characteristic of CR is increased plasma
lowing characteristics: (a) It can be triggered by proteanmembrane resistance to attack. Therefore, this study sought
renal insults, for example, innumerable nephrotoxins [1–5],to identify potential changes in plasma membrane lipid compo-
sition in CR tubules/renal cortex and, if present, to test whether ischemia reperfusion [6, 7], urinary tract obstruction [8],
they might mechanistically contribute to the CR state. and acute glomerulonephritis [9, 10]. (b) The resulting
Methods. Renal cortices/isolated tubules were obtained from CR is broad based in its expression (that is, one form of
CR mouse kidneys (18-hr postinduction of ischemia reperfusion, injury, such as ischemia, confers cross protection against
myoglobinuria, or ureteral obstruction). Their plasma membrane others, for example, nephrotoxins) [1, 7–11]. (c) It gener-phospholipid/cholesterol profiles were compared with those
ally requires a delay, or “lag time,” of 18 to 24 hours toobserved in either control tissues or tissues obtained one to two
develop [6, 7, 12]. (d) The protection likely has a multifac-hours post-renal damage (that is, prior to emergence of CR).
torial basis (for example, up-regulation of cytoprotectiveResults. Either no changes or inconsistent changes in phos-
proteins, such as hemeoxygenase, ferritin, decreased freepholipid profiles were observed in CR tissues. Conversely, CR
(vs. control) tissues demonstrated a consistent 25 to 50% in- radical generation, etc.) [10, 11, 13–15]. (e) Although
crease in membrane cholesterol content. To ascertain whether cytoprotective “stress” proteins may contribute to the
cholesterol impacts tubule susceptibility to injury, its levels CR, it is not completely dependent on them. This is indi-
were reduced in proximal tubule (HK-2) cells with either (a) cated by the fact that complete protein synthesis inhibition
mevastatin, (b) a cholesterol “stripping” agent, (c) cholesterol (for example, with cycloheximide), by itself, induces aoxidase, or (d) cholesterol esterase. Then cell susceptibility to
cytoresistant state [16], and (f) a correlate of tubule CRinjury [adenosine 59-triphosphate (ATP) depletion; Fe-medi-
is a direct increase in plasma membrane resistance toated oxidant stress] was assessed. In each instance, cholesterol
attack. This is indicated by observations that plasmareductions dramatically sensitized to superimposed injury (for
example, a 2 to 3 times increase in the % of lactate dehydroge- membranes of cytoresistant tubules have decreased re-
nase release). When cholesterol levels were restored to normal sponsiveness to oxidative stress and phospholipase A2
in CR tubules (with a “stripping” agent), an increased tubule (PLA2)-mediated deacylation reactions [7, 8, 11].
susceptibility to injury resulted. Because cholesterol decreases Given that a loss of plasma membrane integrity is
membrane fluidity, the impact of a membrane-fluidizing agent generally viewed as the final arbiter of necrotic cell death,
(A2C) on cell injury was assessed. A2C dramatically sensitized a primary increase in membrane resistance to injuryHK-2 cells to superimposed attack.
could be a critical determinant of the acquired cytoresis-Conclusions. ARF leads to an up-regulation of proximal
tant state. However, the biochemical/biophysical basistubule cholesterol content. The latter may then contribute to
for this change in membrane susceptibility to injury hasacquired CR, possibly by stabilizing the plasma membrane via
its antifluidizing effect. not been defined. As part of this laboratory’s ongoing
investigation of this area, we have observed a dramatic
increase in cholesterol content in cytoresistant renal cor-
Key words: acute renal failure, oxidant stress, ATP depletion, meva- tex and in proximal tubules isolated from it. Additional
statin, fluidity, phospholipids. evidence suggests that this change in cholesterol expres-
sion can decrease membrane susceptibility to injury, po-Received for publication April 15, 1999
tentially contributing to the cytoresistant state. The ex-and in revised form June 9, 1999
Accepted for publication June 16, 1999 periments that provide the basis for these conclusions
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METHODS (b) Bilateral obstruction. Six anesthetized mice were
treated as discussed earlier in this article, except thatExperimental in vivo renal injury protocols
bilateral ureteral obstruction (BUO) was induced. Ap-Male CD-1 mice (25 to 50 g; Charles River Labora-
proximately 18 hours later, the kidneys were removed,tories, Wilmington, MA, USA) maintained under rou-
and cortical tissues were obtained for cholesterol andtine vivarium conditions with free food and water access
phospholipid analysis. Control renal tissues were obtainedwere used for all experiments. All surgical procedures
from six mice subjected to concomitant sham surgery.were conducted under deep pentobarbital anesthesia
Acute renal injury effects on cholesterol expression.(approximately 2 mg intraperitoneal injection), as de-
Unlike the studies that assessed cholesterol levels at ap-noted later in this article.
proximately 18-hours postinjury (when CR is expressed),Ischemia: 18-hour reperfusion injury protocol. Seven
in these experiments, cholesterol levels were determinedmice were subjected to a midline abdominal incision,
two hours after injury induction (when CR is not ex-exposing both renal pedicles. The right renal pedicle was
pressed) [7].ligated, and the kidney was removed. The left kidney
(a) Myohemoglobinuria. Six mice were injected withwas subjected to 25 minutes of ischemia induced by renal
10 ml/kg glycerol, as noted earlier in this article, and twopedicle occlusion with a microvascular clamp. The body
hours later, the kidneys were harvested for renal corticaltemperature was maintained with extracorporeal heating
cholesterol analysis. Six simultaneously obtained normallamps at 36 to 378C during the ischemic period. Following
kidneys provided control tissue cholesterol levels.the ischemic period, the vascular clamp was removed,
(b) Ischemia/reperfusion. Three mice were subjectedand the abdominal cavity was sutured in two layers with
to 25 minutes of unilateral renal ischemia and then 35silk suture. The animals were then placed in a 378C heating
minutes of reperfusion at 378C. At their completion,chamber until recovery from anesthesia. Approximately
both kidneys were removed for renal cortical cholesterol18 hours later, a time at which renal tubular CR is expressed
determination.[6, 7], the animals were re-anesthetized. The abdominal
cavity was re-opened, and the left kidney was resected. Tissue phospholipid and cholesterol analysis
It was placed on an iced plate, and approximately 100 mg
Recovered cortical tissue samples (approximately 100of cortex were dissected and saved for either cholesterol
mg) were added to four parts of methanol and wereor phospholipid analysis, as described later in this article.
homogenized for approximately 30 seconds. An aliquotKidneys obtained from seven normal mice and from five
of each homogenate (250 ml) was added to 3 ml ofmice subjected to unilateral nephrectomy, but not contra-
chloroform:methanol (1:2). The samples were sonicatedlateral renal ischemia, were used to establish normal/
for 15 minutes, and then 2 ml of chloroform 1 2 ml ofcontrol renal cortical cholesterol/phospholipid profiles.
1 m NaCl were added. The samples were vortexed forMyohemoglobinuric injury protocol. Five anesthetized
30 seconds and then centrifuged at 2000 rpm 3 10 min-mice were injected with 10 ml/kg of 50% glycerol, admin-
utes. The upper phase was discarded. Four milliliters ofistered in equally divided doses into each upper hind
chloroform:methanol:water (3:48:47) were added, fol-limb. The mice were maintained at 378C until recovery
lowed by further vortexing and centrifugation (320 min).from anesthesia. Approximately 18 hours later, a time at
The lower phase was removed with a pipette. It waswhich renal CR is expressed [11, 13], the mice were re-
transferred to a new glass tube and dried under nitrogen.anesthetized. The abdominal cavities were opened, and
The original sample was re-extracted as mentioned ear-then the kidneys were removed to provide cortical tissues
lier in this article and was added to the first extract. Thefor cholesterol/phospholipid analysis. Five normal mice
final sample underwent a series of volume reductionswere used to obtain control cortical tissue samples.
under nitrogen to approximately 400 ml. Ten millilitersObstructive nephropathy. Either bilateral or unilateral
were used to determine inorganic phosphate content ac-ureteral obstruction (UO) can confer CR [8]. The follow-
cording to the method of Van Veldhoven and Mannaertsing protocols were undertaken to ascertain whether these
[17]. Approximately 20-ml samples were used to quanti-two states alter cholesterol/phospholipid expression.
tate individual plasma membrane phospholipid species(a) Unilateral obstruction. Six anesthetized mice were
(phosphatidyl-choline, -serine, -ethanolamine, -inositol;subjected to a midline laboratomy. The left ureter was
sphingomyelin) by two-dimensional thin-layer chroma-ligated with a silk ligature at its approximate midpoint,
tography (2D TLC), as previously described in detailwhereas the right kidney was left undisturbed. The ani-
[18]. The remaining extract was dried under nitrogen.mals were maintained at 378C until recovery from anes-
The sample was resuspended in 10 ml of methanol andthesia. Approximately 18 hours later, both kidneys were
assayed for total cholesterol content using a commer-resected, and cortical tissue samples were collected for
cially available cholesterol kit (Sigma #352; Sigma Chem-cholesterol analysis. The results from the obstructed kid-
ical Co., St. Louis, MO, USA). In brief, this assay subjectsneys were compared with their contralateral and, hence,
surgically matched, controls. total cholesterol to treatment with cholesterol esterase
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(to deacylate cholesterol esters) plus cholesterol oxidase imately six hours after seeding, wells of cells within each
plate were either left under control conditions or were(CO). The latter then converts cholesterol to cholest-
treated with 5 or 10 mm mevastatin (Sigma Chemicals,4-en-3-one 1 H2O2, the latter being quantitated by a
M-2537) 3 18 hours [22]. The mevastatin was addedcolorimetric technique.
from a 10 mm stock solution made up in ethanol (final
Cholesterol measurements in isolated proximal tubules ethanol concentration, # 0.1%). The control cells within
each plate were exposed to the same amount of ethanolThe following experiment was conducted to ascertain
without mevastatin addition. Then the following experi-whether the changes in cholesterol expression in renal
ments were conducted.cortical tissues (Results section) reflects, at least in part,
Four-hour FeHQ injury protocol. Wells of cells werea proximal tubular cell event. To this end, 12 mice were
maintained for approximately 18 hours under either con-anesthetized and subjected to either sham glycerol or
trol conditions (mevastatin vehicle) or with mevastatinglycerol injection (N 5 6 each). Eighteen hours later, the
exposure (5 or 10 mm). They were then either left unper-kidneys were removed, and proximal tubule segments
turbed under these conditions, or they were subjected to(PTSs) were isolated from renal cortices, as previously
a 7.5 mm FeHQ challenge (still in the presence of meva-described [8, 11, 15]. Following their isolation, they were
statin). Four hours later, cell viability was assessed bysubjected to lipid extraction [18] and were then assayed
measuring cell uptake of the tetrazolium dye, 3-(4,5-for cholesterol content, as noted earlier in this article.
dimethylthiazol-2-yl)-2,5-diphenytetrazolium (MTT; the
suppression of MTT uptake equates with cell injury/cellCultured proximal tubular (HK-2) cell experiments
death) [16, 19]. The cells that were exposed to the 0, 5,The following experiments were undertaken in order
or 10 mm mevastatin dosages but not the FeHQ challengeto manipulate cholesterol levels within proximal tubular
were used to establish baseline MTT values and to gaugecells and thereby assess whether cholesterol is a determi-
possible independent mevastatin effects (that is, in thenant of cellular susceptibility to injury. HK-2 cells, an
absence of the FeHQ challenge). The individual groupsimmortalized proximal tubular cell line derived from
created by this protocol are depicted in the Results section.normal human kidney [19] and maintained under pre-
Eighteen-hour FeHQ injury protocol. Wells of cellsviously described conditions, were used for this purpose.
were maintained for approximately 24 hours with eitherIn brief, the cells were maintained in culture (378C, 5%
10 mm mevastatin or with mevastatin vehicle. They wereCO2) in T75 Costar flasks (Cambridge, MA, USA) with then maintained under either of these conditions for ankeratinocyte serum-free medium (K-SFM; GIBCO Life
additional 18 hours or were subjected to an 18-hourTechnologies, Grand Island, NY, USA). The medium
FeHQ challenge (either 5 or 7.5 mm). The original mev-
contained 1 mm glutamine, 5 ng/ml epidermal growth astatin dosages (0 or 10 mm) were maintained throughout
factor, 40 mg/ml bovine pituitary extract, 25 U/ml penicil- these treatments. The individual experimental groups
lin, and 25 mg/ml streptomycin. At near confluence, the generated by this protocol are depicted in the Results
cells were trypsinized [19] and transferred to either addi- section. At the completion of the experiments, cell injury
tional T75 flasks (for passage or biochemical analysis) was determined by percentage lactate dehydrogenase
or to 24-well Costar plates for individual experiments, (LDH) release, as previously described [20].
as described later in this article. Two extensively charac- Four-hour ATP depletion/Ca21 overload injury proto-
terized HK-2 cell injury models were then employed for col. Cells pretreated 3 18 hours with either 0, 5, or 10
specific experiments: (a) ATP depletion/cytosolic cal- mm mevastatin were challenged with the ATP depletion/
cium overload injury (addition of 7.5 mm antimycin 1 Ca21 ionophore injury protocol (“CAD” 5 Ca21 iono-
10 mm 2-deoxyglucose 1 5 mm A23187 Ca21 ionophore) phore A23187 1 antimycin A 1 2-deoxyglucose) for
[16] or (b) iron (Fe)-mediated oxidative stress [addition four hours, as previously described [16]. This challenge
of ferrous ammonium sulfate, complexed to 8-hydroxy- was conducted in the presence of the original mevastatin
quinoline (HQ), a siderophore permitting ready intracel- dose. After completing the four-hour challenge, cell in-
lular access (5 or 7.5 mm of each reagent, forming jury was assessed by the MTT uptake, as noted earlier
“FeHQ”)] [20, 21]. in this article. Cells in each plate subjected to each of
these mevastatin treatments (0, 5, 10 mm), but not the
Impact of cholesterol synthesis blockade on HK-2 CAD challenge, served to establish control MTT uptake
cell injury values. The experimental groups created by this protocol
The following experiments tested whether treatment are depicted in the Results section.
of HK-2 cells with mevastatin, an inhibitor of HMG Eighteen-hour ATP depletion/Ca21 overload injury pro-
coreductase (the rate-limiting enzymatic step in choles- tocol. Cells were pretreated for 24 hours with either 0, 5,
terol synthesis), alters HK-2 cell susceptibility to injury. or 10 mm mevastatin. They were then either left under
HK-2 cells were plated into 24-well cluster plates at a these conditions for an additional 18 hours or were sub-
jected to the CAD challenge for 18 hours. At the enddensity of approximately 1.5 3 105 cells per well. Approx-
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of this time, cell injury was assessed by the percentage Biochemical cholesterol modification: Impact on
of LDH release. The individual treatments created by cell injury
this protocol are depicted in the Results section. To further explore the role of plasma membrane cho-
lesterol on maintaining cellular integrity during acutePlasma membrane cholesterol depletion:
injury, plates of HK-2 cells were treated as follows: (a)Methyl-cyclodextrin experiments
control incubations 1 0.1 unit/ml CO (C7149; Sigma),
As a second approach toward assessing the impact (b) control incubations 1 0.1 unit/ml cholesterol esterase
of cholesterol levels on cell susceptibility to injury, (Sigma, C9281), and (c) each of the above conditions
cells were treated with a cholesterol extraction agent, with either a superimposed FeHQ (5 mm) or CAD chal-
methyl-b cyclodextrin (MCD) [22, 23]. lenge. The individual groups created by these treatments
Four-hour CAD or FeHQ-mediated injury. Cells grown are presented in the Results section. After 18 hours un-
in 24-well cluster plates for 18 hours were divided into der these conditions, cell injury was assessed by the per-
two treatment groups: either (a) continued control incu- centage of LDH release.
bation or (b) treatment with 2.5 mm MCD (Sigma Chemi-
cals, C-4555). After a one-hour exposure, the media were Effects of a membrane-fluidizing reagent on cellular
removed and replaced with fresh media. Half of the wells susceptibility to injury
within either the MCD pretreated group or the control Cholesterol decreases the fluidity of cell membranes
incubation group were subjected to either the CAD or [24–26]. The following experiment was undertaken to
the 7.5 mm FeHQ challenge. Four hours later, cell viability ascertain whether membrane fluidity impacts the severity
was assessed by MTT assay. The individual groups created of cell injury responses.
by this protocol are depicted in the Results section. Four-hour ATP depletion/Ca21 ionophore challenge.
Eighteen-hour CAD or FeHQ-mediated injury. This HK-2 cells were grown in 24-well plates under normal
experiment was repeated as noted earlier here with the culture conditions. They were then divided into three treat-
following exceptions: (a) The challenges (FeHQ 1 MCD; ment groups: exposure for one hour to 0, 50, or 200 mm
CAD 1 MCD) were left in place for 18 hours. (b) The
“membrane fluidizing agent” [A2C: 2-(2-methoxyeth-FeHQ challenge was 5 mm, rather than 7.5 mm, and (c)
oxy) ethyl 8-(cis-2-n-octyl cyclopropyl) octanoate; Sigma
the extent of cell injury at the end of the 18-hour chal-
F-3754) [27]. The A2C was solubilized in DMSO (finallenges was assessed by the percentage of LDH release.
cell DMSO concentration # 1%). The control wells were
treated with 1% DMSO alone. After completing theMevastatin and methyl-b cyclodextrin effects on HK-2
one-hour pretreatment period, half of the wells in eachcholesterol levels
group underwent the four-hour CAD challenge. TheThe following experiments were undertaken to con-
extent of cell injury was then assessed by MTT assay, asfirm that mevastatin and MCD were, in fact, effective
noted earlier in this article. The individual experimentalin causing partial cholesterol depletion in HK-2 cells. In
groups created by these treatments are depicted in theorder to have sufficient material for cholesterol analysis,
Results section.the following experiments were performed in T75 flasks
Eighteen-hour ATP depletion/Ca21 ionophore chal-rather than in 24-well cluster plates.
lenge. This experiment was repeated exactly as de-Mevastatin effect. Following seeding of 12 T75 flasks,
scribed earlier here, with the exception that the A2C andthe cells were grown for 48 hours, six under normal
the CAD challenges were left in place for 18 hours. Atconditions and six in the presence of 10 mm mevastatin.
the end of this period, cellular injury was assessed byThe cells were then detached from the flasks with a
percentage LDH release.“rubber policeman,” and the recovered material was sub-
jected to lipid extraction, as previously described [20].
Impact of MCD treatment on cytoresistant mouseThe material was then assayed for cholesterol and total
proximal tubulesphospholipid phosphate, as noted earlier.
In each of the previous experiments, cholesterol levelsMCD effect. Fifteen T75 flasks, seeded with HK-2
were manipulated in otherwise normal cells, thereby low-cells 24 hours previously, were divided into three experi-
ering them to subnormal values (either by blocking syn-mental groups: (a) continued control incubation, (b) ad-
thesis, chemical “stripping” with MCD, or enzymaticdition of 2.5 mm MCD, or (c) addition of 5 mm MCD
modification). In the following experiment, cholesterol(N 5 5 flasks each). After a one-hour exposure, the
was lowered from a supranormal to a normal value inmedia were removed, and the cells were washed three
cytoresistant tubules to ascertain whether this treatmenttimes with Hank’s balanced salt solution (HBSS). The
might mitigate the cytoresistant state. Four mice werecells were then detached from the flasks, as noted earlier
injected with glycerol, and 24 hours later, cytoresistantin this article, followed by cholesterol and phospholipid
phosphate assay. PTSs [11] were prepared. They were then divided into
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lesterol elevation observed at 18-hour postglycerol injec-
tion was not simply an artifact resulting from myohemo-
globinuria).
Ischemia-reperfusion (I/R) injury recapitulated these
glycerol results: By 18-hours postinjury, significant cho-
lesterol elevations were observed (Fig. 1). Conversely,
no cholesterol increase was observed after completing
one hour of ischemic-reperfusion injury (controls, 0.16 6
0.003, postischemia 0.167 6 0.006, P 5 NS).
Unilateral ureteral obstruction (UO) and bilateral
Fig. 1. Cholesterol levels in renal cortex from normal mice and from ureteral obstruction (BUO) each induced significant cho-
mice 18-hours postglycerol (glyc)-induced myohemoglobinuria, ische- lesterol increments (Fig. 1). In contrast, unilateral ne-mia/reperfusion (I/R), unilateral ureteral obstruction (UO), bilateral
phrectomy (Uni-Nx) did not increase cholesterol in theureteral obstruction (BUO), or unilateral nephrectomy (uni-Nx). The
control (C) tissues were obtained from either normal mice or sham- remaining kidney, indicating that the cholesterol eleva-
operated mice, as described in the text. Each injury model caused tions in the unilaterally obstructed kidney could not besignificant cholesterol elevations (nmol/nmol phosphate) compared
explained simply by surgical stress or an adaptation towith the pair-run controls. In contrast, unilateral nephrectomy caused
no cholesterol elevation. a functional reduction in renal mass.
Phospholipid profiles following renal injury
In contrast to the above analyses, which revealed a
four equal aliquots and were incubated 3 45 minutes in consistent increase in cholesterol expression 18 hours
Erlenmeyer flasks [11] as follows: (a) control incu- following glycerol, I/R, and obstructive injury, these in-
bation 3 45 minutes [11], (b) incubation with 2.5 mm jury models induced no consistent changes in renal corti-
MCD 3 45 minutes, (c) 15-minute incubation, followed cal phospholipid profiles. For example, at 18-hours post-
by 15 or 30 minutes of hypoxia (95% N2/5% CO2), and ischemia, there was only a trivial decrease in percentage
(d) 15-minute incubation with 2.5 mm MCD followed by contribution of phosphatidylethanolamine (PE) to the
15 or 30 minutes of hypoxia. At the completion of these total phospholipid mass, with a corresponding increase
incubations, cell injury was gauged by the percentage of in percentage phosphatidylcholine (Table 1). In contrast,
LDH release. The MCD remained in place throughout the 18-hour postglycerol samples did not manifest this
these incubations. (Of note, pilot experiments indicated PE change but instead showed a slight increase in the
that this 2.5 mm MCD treatment reduced cholesterol percentage of sphingomyelin expression. Finally, there
levels in postglycerol tubules by approximately 25%, were no significant changes in the 18-hour postureteral
thereby restoring cholesterol levels back to a normal obstruction phospholipid profiles. (Thus, the previously
concentration). noted cholesterol increments appeared to be a relatively
specific and uniform change in membrane lipid composi-Calculations and statistics
tion following diverse forms of renal damage).
In the cell culture experiments, each protocol was
tested on three or more separate occasions, with each Cholesterol assessments in isolated renal tubules
intervention being tested at least four times in a given Cholesterol levels were significantly elevated in proxi-
plate. All values were compared by paired or unpaired mal tubules harvested from mice at 18-hours postglycerol
Student’s t-test, as appropriate. Cholesterol values are injection (0.25 6 0.02 vs. 2.0 6 0.01, P , 0.01). Thus,
given as nmol/nmol phospholipid phosphate. All values these changes mirrored those observed in whole renal
are given as means 6 1 sem. If multiple comparisons cortex.
were made, the Bonferroni correction was applied.
Mevastatin effects on cell injury
Four-hour FeHQ injury experiments. Pretreating HK-2RESULTS
cells with either 5 or 10 mm mevastatin for 18 hours did
Renal cortical cholesterol levels following tissue injury not alter HK-2 cell viability, as assessed by MTT uptake
Normal renal cortex contained approximately 0.2 (Fig. 2, left). The four-hour FeHQ challenge lowered
nmol of cholesterol per nmol phospholipid phosphate. MTT uptake to 58% of basal values. When the FeHQ
By 18-hours postglycerol (glyc) injection, an approxi- challenge was applied to cells pretreated with 5 and 10
mate 50% increase in cholesterol was apparent (P , mm mevastatin, a potentiation of this Fe-mediated injury
0.005; Fig. 1). By contrast, no significant increase in cho- resulted (MTT uptake falling from 58% to 50% and 48%
lesterol levels was observed at two-hours postglycerol of basal values, respectively, P , 0.05 to 0.005).
Eighteen-hour FeHQ injury experiments. Mevastatininjection (data not shown). (This indicates that the cho-
Zager et al: Cholesterol impacts tubular injury 1793
Table 1. Plasma membrane phospholipid expression in cytoresistant renal cortex
Group % SM % PC % PI % PS % PE
Control 12.060.3 44.360.4 6.360.2 7.060.1 30.460.2
18 hr I/R 12.2 61.4 45.560.3 7.260.4 6.660.2 28.560.5
P (N 5 7) NS ,0.02 NS NS ,0.0025
Control 11.760.5 43.161.5 6.760.2 7.260.3 29.560.9
18 hr glyc. 13.5 60.4 44.960.7 7.060.7 7.360.6 29.160.7
P (N 5 5) ,0.01 NS NS NS NS
Control 13.360.6 43.061.9 7.160.6 7.560.7 29.161.0
24 hr obstn 13.7 60.6 43.263.3 7.861.3 9.061.2 26.360.8
P (N 5 3) NS NS NS NS NS
Values are mean 6 sem. The values represent the % to which each phospholipid contributed to the total phospholipid content (as assessed by inorganic phosphate
recovered in the lipid extract). Abbreviations are: I/R, 18 hrs post-ischemic-reperfusion injury; glyc, 18 hrs post-glycerol induced myohemoglobinuria; obstn, 18 hrs
post-bilateral ureteral obstruction; SM, sphingomyelin; PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine; PE, phosphatidylethanolamine.
Statistical comparisons by unpaired Student’s t-test (N 5 number of paired determinations made).
Fig. 4. Effect of mevastatin (Meva) on four hours of CAD-mediatedFig. 2. Effect of mevastatin on proximal cell (HK-2) MTT uptake
cell injury (CAD 5 Ca21 ionophore 1 antimycin A 1 2 deoxyglucose;under basal conditions ( ) and following a four-hour oxidant challenge
discussed in text). Meva (either 5 or 10 mm) did not independentlywith iron complexed to 8-hydroxyquinoline (FeHQ; j). In the absence
affect MTT uptake (that is, in the absence of CAD). However, bothof the iron challenge, mevastatin did not alter MTT uptake. The iron
Meva doses significantly worsened CAD-mediated depressions in MTTchallenge caused an approximate 50% suppression of MTT uptake
uptake/cell injury, assessed four hours after CAD addition. Symbols(indicative of acute cell injury). Mevastatin caused a modest, dose-
are: ( ) no CAD; (j) CAD.dependent worsening of this Fe-mediated injury, as assessed at the
completion of the four-hour Fe challenge.
presence of either a 5 or 7.5 mm FeHQ challenge (Fig.
3, middle and right). (Thus, with both a 4- and 18-hour
FeHQ challenge, mevastatin worsened Fe-mediated in-
jury, as assessed by two independent injury endpoints:
MTT uptake and LDH release).
Four-hour CAD injury experiments. Neither 5 nor 10
mm mevastatin treatment independently affected MTT
uptake (Fig. 4, left and right panels). CAD lowered MTT
values by approximately 50%. Both 5 or 10 mm meva-
statin pretreatment significantly (P , 0.001) worsened
this CAD-mediated injury (Fig. 4).
Fig. 3. Effect of mevastatin on an 18-hour iron-mediated oxidant Eighteen-hour CAD injury experiments. Mevastatin
(FeHQ) proximal tubule (HK-2) cell challenge, as assessed by the did not independently affect LDH release. However,
percentage of lactate dehydrogenase (LDH) release. In the absence of
mevastatin significantly worsened CAD-mediated per-FeHQ treatment (0), mevastatin had no effect on LDH release. How-
ever, mevastatin worsened LDH release in the presence of both the 5 centage LDH release and in a dose-dependent fashion
mm and the 7.5 mm FeHQ challenge, consistent with a potentiation of (22, 37, and 55% LDH release with 0, 5, and 10 mm
cell injury. Symbols are: ( ) no mevastatin; (j) 10 mm mevastatin.
mevastatin concentrations, respectively; Fig. 5).
MCD/cell injury experiments
Four-hour FeHQ and CAD injury experiments. MCDtreatment did not independently affect HK-2 cell per-
exerted no direct cytotoxicity on the HK-2 cells, slightlycentage of LDH release (Fig. 3, left). However, it signifi-
cantly potentiated the percentage of LDH release in the raising, rather than lowering, their MTT uptake (Fig.
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Fig. 5. Mevastatin effect on CAD-mediated cell injury, assessed by
the percentage of LDH release. Neither mevastatin (Meva) dose had Fig. 7. Effect of MCD on FeHQ- and CAD-mediated cell injury. These
an independent effect on the percentage of LDH release. However, experiments were performed as those depicted in Figure 6 with the
both doses exacerbated LDH release in the presence of the CAD exceptions being as follows: (a) The CAD and Fe challenges were for
challenge, consistent with an enhancement of cell death. Symbols are: 18 hours, rather than 4 hours, and (b) cell injury was assessed by
( ) no CAD; (j) CAD. percentage LDH release. Without exerting an overt intrinsic cytotoxic
effect, MCD dramatically increased cell injury in the presence of the
Fe and CAD challenges. Abbreviation is: C, controls (no MCD).
Fig. 6. Effect of methyl-b cyclodextrin (MCD) on FeHQ- and CAD-
mediated cell injury. MCD treatment slightly raised, rather than lowered, Fig. 8. Effect of mevastatin (Meva) and methyl-b cyclodextrin (MCD)
MTT cell uptake. However, when the cells were challenged with either on HK-2 cell cholesterol levels. Culturing cells with Meva caused an
FeHQ or CAD for four hours, MCD significantly exacerbated the extent approximate 36% reduction in cholesterol content (nmol/nmols phos-
of cell injury that resulted. Abbreviation is: C, controls (no MCD). pholipid phosphate). A one-hour exposure to MCD, a cholesterol “strip-
ping” agent, caused dose-dependent reductions in HK-2 cell cholesterol
content. Abbreviation is: C, controls (no meva or MCD).
6, left panel). However, when added during the FeHQ
challenge, MCD caused a significant lowering of absolute
Impact of cholesterol oxidase and esterase on HK-2MTT uptake, indicating a potentiation of cell injury (Fig.
cell injury6, middle panel). Pretreating the cells with MCD dramat-
ically worsened CAD-mediated cytotoxicity (equating As shown in Figure 9 (left), CO had no independent
with 44 6 7% vs. 80 6 3% losses of baseline MTT uptake effect on HK-2 cell viability. However, it dramatically
without vs. with MCD treatment, respectively, P , sensitized cells to both Fe- and CAD-mediated attack
0.0001; Fig. 6, right panel). (for example, with CAD, raising the percentage of LDH
Eighteen-hour FeHQ and CAD injury experiments. release from 34 6 3% to 82 6 3%). A virtually identical
An 18-hour exposure to MCD had essentially no effect potentiation of both Fe- and CAD-mediated injury was
on HK-2 cell viability (Fig. 7). However, it dramatically induced with cholesterol esterase treatment (Fig. 9, right).
predisposed the cells to both FeHQ- and CAD-mediated
Effect of A2C on severity of HK-2 cell injuryattack (approximately 2 to 4 times increase in % LDH
Four-hour CAD challenge. A2C caused no indepen-release).
dent cytotoxicity, tending to increase rather than de-
Mevastatin and MCD effects on HK-2 cell crease MTT uptake (Fig. 10). However, in the presence
cholesterol levels of the CAD challenge, A2C worsened the extent of cell
injury and in a dose-dependent manner (Fig. 10). ThisAs shown in Figure 8, mevastatin treatment caused a
36% reduction in HK-2 cell cholesterol levels. MCD also worsening corresponded to 64 6 5%, 78 6 4%, and 86 6
3% losses of baseline MTT uptake with CAD in thelowered HK-2 cell cholesterol content and in a dose-
dependent fashion (37 and 47% reductions with 2.5 and presence of 0, 50, and 200 mm A2C, respectively (P ,
0.0015).5 mm MCD, respectively).
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Fig. 11. Effect of A2C on the expression of CAD-mediated cell injury,
as assessed by the percentage of LDH release. A2C had no independentFig. 9. Effect of cholesterol modification by either cholesterol oxidase
effect on LDH release (indicating no intrinsic cytotoxicity). However,(left panel; j) or cholesterol esterase (right panel; j) on the expression
A2C dramatically potentiated CAD-mediated injury and in a dose-of FeHQ- and CAD-mediated injury, as assessed after 18-hour chal-
dependent fashion. Symbols are: ( ) no CAD; (j) CAD.lenges with by LDH release. Cholesterol modification with either agent
caused a marked, statistically significant, increase in both Fe and CAD-
mediated percentage LDH release. Symbol ( ) is the control.
DISCUSSION
Although it is universally accepted that acute tubular
injury leads to cellular adaptations that confer resistance
to subsequent toxic and ischemic insults, the biological
basis for this “acquired CR” and the subcellular site(s)
at which it is expressed have remained subjects of debate.
Given that a loss of plasma membrane integrity is essen-
tially synonymous with necrotic cell death, we have pre-
viously hypothesized that some physical and/or chemical
change within the plasma membrane, stemming from
prior injury, might help impart membrane and hence
cellular resistance to attack [11]. Supporting this possibil-
ity are our previous observations that plasma membranes
Fig. 10. Impact of A2C [2-(2-methoxyethoxy) ethyl 8-(cis-2-n-octyl of cytoresistant tubular cells have decreased vulnerabil-
cyclopropyl) octanoate] on the severity of CAD-mediated cell injury, ity to direct oxidant and PLA2-induced lipid peroxidationas assessed by MTT uptake. A2C slightly raised rather than decreased and phospholipid deacylation, respectively [8, 11]. TheseMTT uptake under basal conditions. However, in the presence of the
CAD challenge, an exacerbation of cell injury (reductions in MTT considerations have led us to search for a cell injury-
uptake) resulted. Symbols are: ( ) no CAD; (j) CAD. initiated adaptational change(s) in membrane lipid com-
position, which could potentially give rise or contribute
to the cytoresistant state.
As an initial exploration of this issue, we comparedEighteen-hour CAD challenge. As depicted in Figure
renal cortical plasma membrane phospholipid profiles11, 18-hour exposures to either 50 or 200 mm A2C had
(PC, PS, PE, PI, SM) of normal mice with those obtainedno effect on HK-2 cell percentage of LDH release. How-
from mice with an established cytoresistant state. Highlyever, A2C caused a dramatic, dose-dependent exacerba-
divergent methods were used to trigger the latter (I/R,tion of CAD-mediated LDH (Fig. 11, right), thereby
glycerol, unilateral/BUO) because it was reasoned thatsupporting the findings from the previously mentioned
if a common phospholipid change emerged from veryfour-hour/MTT A2C experiments.
different injury models, it would suggest potential mech-
Methyl-b cyclodextrin effects on cell injury in anistic relevance. However, as demonstrated in Table 1,
cytoresistant tubules only trivial and inconsistent changes in phospholipid pro-
files were observed. This led us to reject the hypothesisMethyl-b cyclodextrin did not independently affect
that altered phospholipid composition confers CR andLDH release from cytoresistant tubule (controls, 12 6
to consider an alternative possibility, which is that altered2%; MCD, 13 6 2%). The 15- and 30-minute hypoxic
plasma membrane cholesterol expression might be in-challenges induced an 18 6 0.5% and 55 6 0.5% LDH
volved.release. In each instance, MCD exacerbated these hyp-
Indeed, with each injury model tested, a 25 to 50%oxia-mediated LDH increments (to 28 6 2% and 64 6
2%, respectively, P , 0.01). increase in cholesterol levels was observed in renal cortex,
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relative to the total phospholipid mass. It is noteworthy cholesterol’s role as an arbiter of cell injury, plasma
membrane cholesterol was biochemically modified withthat these cholesterol elevations were observed at 18
hours, but not at one- to two-hours postinjury. Because either CO or cholesterol esterase, rather than simply
reducing its concentration (that is, with mevastatin orCR is expressed at the latter, but not at the former time
point [1, 6, 7, 12], this temporal correlation suggests a MCD). Each of these cholesterol modifications induced
a dramatic potentiation of both Fe and ATP depletion/possible mechanistic link between these two phenomena.
Because CR is expressed directly at the proximal tubular Ca21 ionophore injury. In summary, four highly diver-
gent approaches for modifying plasma membrane choles-cell level [7, 8, 11, 16] if an increase in cortical cholesterol
were to play a mechanistic role, it would need to be terol expression (decreased synthesis, physical removal,
de-esterification, and oxidation) each support the sameexpressed directly within the proximal tubular epithe-
lium. This was subsequently shown to be the case, as conclusion: that plasma membrane cholesterol is a criti-
cal determinant of proximal tubular resistance to attack.an approximate 25% increase in cholesterol levels was
observed in tubules harvested from glycerol-initiated cy- In each of these experiments, cholesterol was lowered
to a subnormal value, and increased cell injury resulted.toresistant renal cortex [11].
To further pursue the hypothesis that increased cho- However, it does not necessarily follow that restoring a
normal cholesterol from a previously high value wouldlesterol expression might help confer CR, we next manip-
ulated cholesterol levels in HK-2 cells to ascertain produce the same result. To pursue this possibility, cyto-
resistant proximal tubules were harvested from glycerol-whether a change in cellular susceptibility to injury might
result. It was reasoned that if cholesterol elevations im- treated mice [11], and their cholesterol content was re-
stored back to normal values (with MCD) to ascertainpart cytoprotection, a lowering of cholesterol should ren-
der tubular cells more vulnerable to superimposed at- whether increased cellular susceptibility to injury would
result. MCD had no apparent direct adverse effect ontack. An alternative and more direct approach would
have been to raise cholesterol in tubular cells to su- isolated tubule viability. However, when the tubules
were challenged with either a 15- or 30-minute hypoxicpranormal levels and then ascertain whether CR results.
However, unlike plasma cholesterol levels, which are challenge, increased injury resulted. Hence, these data
provide additional support for the concept that an up-relatively easy to manipulate, it can be extremely difficult
to raise cholesterol within cell membranes because of regulation of proximal tubule cholesterol content is a
potentially important determinant of the acquired cyto-tight physiologic regulation of their cholesterol content.
(Indeed, several different attempts were made to achieve resistant state.
The next experimental issue addressed was how athis result in HK-2 cells, each without success). Because
of this, the previously described “cholesterol depletion” change in cholesterol expression might impact cellu-
lar injury responses. Because cholesterol generally de-approach was chosen to evaluate cholesterol’s impact
on cellular resistance to attack. Using this approach, creases plasma membrane fluidity [25–27], we tested
whether a change in fluidity impacts tubule susceptibilitycompelling data emerged to support the concept that
cholesterol is indeed a critical determinant of cellular to damage. To achieve this objective, HK-2 cells were
exposed to a membrane fluidizing agent, A2C, and thenresistance to injury, as follows: (a) When cholesterol
levels were reduced in HK-2 cells with mevastatin, in- its effect on cell injury was assessed. In each case, the
fluidizing agent induced a striking, dose-dependent in-creased vulnerability to injury resulted. This observation
was confirmed with two completely different injury mod- crease in cellular vulnerability to attack. Given these
findings, a tenable working hypothesis that integrates allels (Ca21 ionophore/ATP depletion; Fe-mediated oxi-
dant stress). Each model was tested with two different of these data is as follows: (a) Cell injury begets an
increase in plasma membrane cholesterol expression. (b)lengths of injury (4 or 18 hr), and two different injury
endpoints were assessed (MTT uptake and LDH re- The latter acts to decrease, or preserve, membrane fluid-
ity during cellular injury, and (c) this decrease in fluiditylease). Completely consistent results were obtained un-
der each of these conditions, underscoring the potential helps mediate the cytoresistant state.
Key questions that emerge from these studies and thatfor cholesterol to alter cell injury responses. (b) Because
HMG coreductase inhibitors can potentially impact cel- will require future exploration are as follows: (a) What
are the mechanisms by which cell injury causes choles-lular homeostasis independent of its effect on cholesterol
levels, for example, by changes in nitric oxide generation, terol accumulation (for example, does it stem from in-
creased synthesis, increased cholesterol extraction fromprotein prenylation [28, 29], a second mechanism was
used to lower cell cholesterol levels: treatment with the blood, or decreased cholesterol catabolism)? (b) To what
extent do the cholesterol elevations impact basal mem-cholesterol “stripping” agent MCD. Once again, a low-
ering of cell cholesterol evoked dramatic injury potentia- brane fluidity, and how does a change in fluidity attenuate
cellular damage? (c) Finally, are cofactors required fortion under each of the experimental conditions described
earlier in this article. (c) As a third approach to assessing cholesterol to exert its apparent cytoprotective effects?
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